← Leaderboards
Lynn Erica Taylor
Miriam Hospital
$882,422
Attributed
$882,422
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $179.2K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$882,422 · 1
By mechanism
K23$882,422 · 1
Top collaborators
No co-investigators on record.
Most similar at Miriam Hospital
Same institution · by research overlap
- Timothy P Flanigan$23,302,591
- Amy Stewart Nunn$7,169,450
- Josiah D Rich$21,388,960
- Philip Andrew Chan$10,525,667
- Rena R Wing$53,376,330
Others in their field
Top investigators on “Feasibility Studies”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- Wafaa M. El-Sadr · Columbia University Health Sciences$130,207,886
- Sten H Vermund · University Of Alabama At Birmingham$117,219,202
- David Heimbrook · Leidos Biomedical Research, Inc.$113,159,067
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Myron S Cohen · Family Health International$101,800,876
Research focus
Feasibility StudiesEnvironmentEpidemicAddictionAgonistAdherence (Attribute)Drug UserAffectBaseBehaviorBuprenorphineCaringCessation Of LifeAids/Hiv ProblemAlcohol Or Other Drugs UseCirrhosisClinical TrialsCommunitiesComorbidityCravingDesignDisease ProgressionDrug UsageFuture
Grant awards (5)
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users$175,268
K23 · FY2012 · DA · contact PI
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users$176,814
K23 · FY2011 · DA · contact PI
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users$176,989
K23 · FY2010 · DA · contact PI
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users$174,139
K23 · FY2009 · DA · contact PI
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users$179,212
K23 · FY2008 · DA · contact PI